Two Sigma Advisers’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-424
Closed -$6.21K 2712
2024
Q1
$6.21K Sell
424
-9
-2% -$132 ﹤0.01% 2423
2023
Q4
$6.3K Buy
433
+128
+42% +$1.86K ﹤0.01% 2470
2023
Q3
$7.27K Buy
305
+42
+16% +$1K ﹤0.01% 2352
2023
Q2
$3.48K Sell
263
-30
-10% -$397 ﹤0.01% 2356
2023
Q1
$22.8K Sell
293
-556
-65% -$43.3K ﹤0.01% 2510
2022
Q4
$70.6K Sell
849
-285
-25% -$23.7K ﹤0.01% 2333
2022
Q3
$104K Sell
1,134
-722
-39% -$66.2K ﹤0.01% 2305
2022
Q2
$278K Sell
1,856
-3,257
-64% -$488K ﹤0.01% 2148
2022
Q1
$1.24M Sell
5,113
-8,373
-62% -$2.03M ﹤0.01% 1521
2021
Q4
$4.08M Sell
13,486
-448
-3% -$135K 0.01% 857
2021
Q3
$5.76M Buy
+13,934
New +$5.76M 0.01% 718
2021
Q2
Sell
-345
Closed -$71K 2736
2021
Q1
$71K Sell
345
-156
-31% -$32.1K ﹤0.01% 2472
2020
Q4
$100K Sell
501
-102
-17% -$20.4K ﹤0.01% 2270
2020
Q3
$100K Sell
603
-801
-57% -$133K ﹤0.01% 2275
2020
Q2
$348K Buy
1,404
+125
+10% +$31K ﹤0.01% 2053
2020
Q1
$233K Sell
1,279
-74
-5% -$13.5K ﹤0.01% 2117
2019
Q4
$392K Sell
1,353
-103
-7% -$29.8K ﹤0.01% 1969
2019
Q3
$397K Sell
1,456
-44
-3% -$12K ﹤0.01% 1805
2019
Q2
$564K Sell
1,500
-9
-0.6% -$3.38K ﹤0.01% 1765
2019
Q1
$404K Sell
1,509
-17
-1% -$4.55K ﹤0.01% 1873
2018
Q4
$325K Buy
1,526
+13
+0.9% +$2.77K ﹤0.01% 1954
2018
Q3
$678K Buy
1,513
+40
+3% +$17.9K ﹤0.01% 1672
2018
Q2
$597K Buy
1,473
+258
+21% +$105K ﹤0.01% 1852
2018
Q1
$663K Buy
1,215
+728
+149% +$397K ﹤0.01% 1717
2017
Q4
$294K Buy
+487
New +$294K ﹤0.01% 1951